Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in human melanoma

被引：0
|
作者：
Silini, A. [1 ]
Ardinghi, C. [2 ]
Carraro, F. [2 ]
Naldini, A. [2 ]
Bani, M. R. [1 ]
Giavazzi, R. [1 ]
机构：
[1] Mario Negri Inst Pharmacol Res, Dept Oncol, Lab Biol & Therapy Metastasis, I-24100 Bergamo, Italy
[2] Univ Siena, Dept Physiol, I-53100 Siena, Italy
来源：
THROMBOSIS RESEARCH | 2007年 / 120卷
关键词：
D O I：
10.1016/S0049-3848(07)70148-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [1] Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype
    Antonietta Silini
    Carmen Ghilardi
    Camilla Ardinghi
    Sergio Bernasconi
    Paolo Oliva
    Fabio Carraro
    Antonella Naldini
    Maria Rosa Bani
    Raffaella Giavazzi
    Clinical & Experimental Metastasis, 2010, 27 : 43 - 53
  • [2] Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype
    Silini, Antonietta
    Ghilardi, Carmen
    Ardinghi, Camilla
    Bernasconi, Sergio
    Oliva, Paolo
    Carraro, Fabio
    Naldini, Antonella
    Bani, Maria Rosa
    Giavazzi, Raffaella
    CLINICAL & EXPERIMENTAL METASTASIS, 2010, 27 (01) : 43 - 53
  • [3] Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias
    Veiga, Camilla de S. B.
    Carneiro-Lobo, Tatiana C.
    Coelho, Claudia J. B. P.
    Carvalho, Silvia M. F.
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    Abdelhay, Eliana
    Mencalha, Andre L.
    Ferreira, Aline F.
    Castro, Fabiola A.
    Monteiro, Robson Q.
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (03) : 230 - 234
  • [4] Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
    Tas, Faruk
    Bilgin, Elif
    Karabulut, Senem
    Erturk, Kayhan
    Duranyildiz, Derya
    BBA CLINICAL, 2016, 5 : 166 - 169
  • [5] Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
    Liu, Xuan
    Yu, Jiahui
    Song, Shangjin
    Yue, Xiaoqiang
    Li, Qi
    ONCOTARGET, 2017, 8 (63) : 107334 - 107345
  • [6] Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins
    Nyarko, KA
    Freedman, J
    Song, YQ
    Gentry, PA
    Ofosu, FA
    THROMBOSIS AND HAEMOSTASIS, 1999, : 817 - 817
  • [7] IN VIVO PROTEASE-ACTIVATED RECEPTOR-1 MEDIATED CORONARY VASOREACTIVITY CORRELATES WITH PAR-1 EXPRESSION DISTRIBUTION IN THE CORONARY VASCULAR WALL
    Kasasbeh, E. S.
    Phillips, S. A.
    Couhtino, L.
    Williams, P.
    Nunnally, A. H.
    Adcock, J.
    Wang, L.
    Hamm, H. E.
    Cleator, J. H.
    CARDIOLOGY, 2015, 131 : 285 - 285
  • [8] De- and resensitization of protease-activated receptor-1 (PAR-1) in rat astrocytes
    Ubl, JJ
    Sergeeva, M
    Reiser, G
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S73 - S73
  • [9] Loss of activator protein-2α results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma
    Tellez, C
    McCarty, M
    Ruiz, M
    Bar-Eli, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 46632 - 46642
  • [10] Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity
    Medipally, Ajay
    Xiao, Min
    Biederman, Laura
    Satoskar, Anjali A.
    Ivanov, Iouri
    Rovin, Brad
    Parikh, Samir
    Kerlin, Bryce A.
    Brodsky, Sergey, V
    PHYSIOLOGICAL REPORTS, 2022, 10 (15):
12345